These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 312810)

  • 21. Complement-dependent lymphocytotoxic antibodies (CLA) in systemic lupus erythematosus preferentially inhibit the generation of alloreactive cytotoxic T cells in secondary CML.
    Huber C; Pfister R; Stingl G
    Clin Exp Immunol; 1982 Dec; 50(3):525-33. PubMed ID: 6219834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
    Tsokos GC; Magrath IT; Balow JE
    J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of La(SSB) on PWM-induced immunoglobulin synthesis by anti-La(SSB) positive SLE patients and healthy controls.
    Smith G; Morrison CA; Maddison PJ
    Clin Exp Immunol; 1987 Jun; 68(3):552-61. PubMed ID: 2958189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
    Weill BJ; Renoux ML
    Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
    Utsinger PD; Yount WJ
    J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus.
    Minota S; Winfield JB
    J Immunol; 1987 Dec; 139(11):3644-51. PubMed ID: 3500225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.
    Sekigawa I; Okada T; Noguchi K; Ueda G; Hirose S; Sato H; Shirai T
    J Immunol; 1987 May; 138(9):2890-5. PubMed ID: 2952727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppressor cell defect in SLE: relationship to native DNA binding.
    Krakauer RS; Clough JD; Alexander T; Sundeen J; Sauder DN
    Clin Exp Immunol; 1980 Apr; 40(1):72-6. PubMed ID: 6446432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of human T-lymphotrophic virus type I in patients with systemic lupus erythematosus.
    Lipka K; Tebbe B; Finckh U; Rolfs A
    Clin Exp Dermatol; 1996 Jan; 21(1):38-42. PubMed ID: 8689767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
    Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
    J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.
    Morimoto C; Reinherz EL; Distaso JA; Steinberg AD; Schlossman SF
    J Clin Invest; 1984 Mar; 73(3):689-700. PubMed ID: 6231307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).
    Morimoto C
    Clin Exp Immunol; 1978 Apr; 32(1):125-33. PubMed ID: 352583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in vitro production and regulation of anti-double stranded DNA antibodies by peripheral blood mononuclear cells from normals and patients with systemic lupus erythematosus.
    Mach PS; Kharouby M; Lutcher F; Olivier JL; Bazely N; Dougados M; Amor B
    Clin Exp Immunol; 1984 Aug; 57(2):338-44. PubMed ID: 6331922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-2 normalizes defective suppressor T cell function of patients with systemic lupus erythematosus in vitro.
    Volk HD; Diamantstein T
    Clin Exp Immunol; 1986 Dec; 66(3):525-31. PubMed ID: 2952381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppressor T cell dysfunction and depressed immunoglobulin production by B cells in vitro in patients with SLE.
    Nishinarita S; Takizawa I; Hirai H; Morita K; Amaki I
    J Rheumatol; 1981; 8(1):19-30. PubMed ID: 6452522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
    Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
    Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.